<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.jnrbm.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Journal of Negative Results in BioMedicine - Latest Articles</title>
        <link>http://www.jnrbm.com</link>
        <description>The latest research articles published by Journal of Negative Results in BioMedicine</description>
        <dc:date>2012-02-02T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/11/1/9" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/11/1/8" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/11/1/7" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/11/1/6" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/11/1/5" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/11/1/4" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/11/1/3" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/11/1/2" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/11/1/1" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/10/1/16" />
                            </rdf:Seq>
        </items>
                 <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.jnrbm.com/content/11/1/9">
        <title>TGFBR3 Variation is not a Common Cause of Marfan-like Syndrome and Loeys-Dietz-like Syndrome</title>
        <description>Marfan syndrome (MFS) is caused by mutations in the fibrillin-1 (FBN1) gene, and mutations in FBN1 are known to be responsible for over 90% of all MFS cases. Locus heterogeneity has also been reported and confirmed, with mutations in the receptor genes TGFBR1 and TGFBR2 identified in association with MFS-related phenotypes. It is now known that dysregulation of TGF-beta signaling is involved in MFS pathogenesis. To test the hypothesis that dysregulation of TGFBR3- associated TGF-beta signaling is implicated in MFS or related phenotype pathogenesis, we selected a cohort of 49 patients, fulfilling or nearly fulfilling the diagnostic criteria for MFS. The patients were known not to carry a mutation in the FBN1 gene (including three 5&apos; upstream alternatively spliced exons), the TGFBR1 and TGFBR2 genes. Mutation screening for the TGFBR3 gene in these patients and in controls led to the identification of a total of ten exonic (one novel), four intronic (one novel) and one 3&apos;UTR variant in the TGFBR3 gene. Our data suggest that variations in TGFBR3 gene appear not to be associated with MFS or related phenotype.</description>
        <link>http://www.jnrbm.com/content/11/1/9</link>
                <dc:creator>Krishna Singh</dc:creator>
                <dc:creator>Joerg Schmidtke</dc:creator>
                <dc:creator>Britta Keyser</dc:creator>
                <dc:creator>Mine Arslan-Kirchner</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2012, null:9</dc:source>
        <dc:date>2012-02-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-11-9</dc:identifier>
                                <prism:require>/content/figures/1477-5751-11-9-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2012-02-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/11/1/8">
        <title>Metallothionein genes: no association with Crohn&apos;s Disease in a New Zealand population</title>
        <description>Metallothioneins (MTs) are excellent candidate genes for Inflammatory Bowel Disease (IBD) and have previously been shown to have altered expression in both animal and human studies of IBD.  This is the first study to examine genetic variants within the MT genes and aims to determine whether such genetic variants have an important role in this disease.  28 tag SNPs in genes MT1 (subtypes A, B, E, F, G, H, M, X), MT2, MT3 and MT4 were selected for genotyping in a well-characterized New Zealand dataset consisting of 406 patients with Crohn&apos;s Disease (CD) and 638 controls.  We did not find any evidence of association for MT genetic variation with CD.  The lack of association indicates that genetic variants in the MT genes do not play a significant role in predisposing to CD in the New Zealand population.</description>
        <link>http://www.jnrbm.com/content/11/1/8</link>
                <dc:creator>Angharad Morgan</dc:creator>
                <dc:creator>Alan Fraser</dc:creator>
                <dc:creator>Lynnette Ferguson</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2012, null:8</dc:source>
        <dc:date>2012-01-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-11-8</dc:identifier>
                                <prism:require>/content/figures/1477-5751-11-8-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2012-01-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/11/1/7">
        <title>Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population </title>
        <description>Background:
: Crohn&apos;s disease (CD) and ulcerative colitis (UC), the two main types of inflammatory bowel disease (IBD), are multifactorial conditions of unknown etiology. The objective of this study is to examine the combined gene-environment interactions influencing IBD susceptibility in a well-defined Caucasian cohort in rural mid-America.MethodS: Patients were diagnosed to have CD or UC using conventional radiologic, endoscopic, and/or histopathologic findings. Histological diagnosis was made by a single specialist gastrointestinal pathologist with a particular interest in IBD. Information regarding cigarette smoke exposure was obtained by administration of the Behavioral Risk Factor Surveillance System Survey (BRFSS) to all patients. Genomic DNA was extracted from peripheral blood leukocytes, and polymerase chain reaction (PCR) amplification and genotyping were performed for 11 Single Nucleotide Polymorphisms (SNP) in NOD2, IL23r, OCTN1 genes along with IGR.
Results:
: Our cohort consists of 1196 patients: 435 controls, 485 CD patients, and 276 UC patients. Only patients with genotype data for at least 7 of 11 SNPs were included in our data analysis. The control groups for all 11 SNPs were in Hardy-Weinberg Equilibrium. In genotype-association SNP analysis, all NOD2 SNPs (rs5743293, rs2066844, rs2066845) and the IL23r SNP (rs11465804) showed a significant association to IBD (p &lt; 0.03). A multiple gene-interaction analysis showed an association between NOD2 and IL23r with UC (p = 0.04). There were no associations between any OCTN1 and IGR SNPs and IBD in this cohort. A multivariable logistic regression analysis showed that female gender, &quot;current&quot; or &quot;former&quot; smoking status, family history of IBD, and NOD2 SNP minor alleles were associated with CD.CONCLUSION: IBD remains to be challenging to properly diagnose, characterize, and treat. Our study proposes a combined genetic, phenotypic, and environmental approach in an attempt to better understand IBD. Previously demonstrated associations between OCTN1 and IGR and IBD were not confirmed.</description>
        <link>http://www.jnrbm.com/content/11/1/7</link>
                <dc:creator>Ziad Kanaan</dc:creator>
                <dc:creator>Maurice Eichenberger</dc:creator>
                <dc:creator>Surriya Ahmad</dc:creator>
                <dc:creator>Clayton Weller</dc:creator>
                <dc:creator>Henry Roberts</dc:creator>
                <dc:creator>Jianmin Pan</dc:creator>
                <dc:creator>Shesh Rai</dc:creator>
                <dc:creator>Robert Petras</dc:creator>
                <dc:creator>E.Brooks Weller</dc:creator>
                <dc:creator>Susan Galandiuk</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2012, null:7</dc:source>
        <dc:date>2012-01-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-11-7</dc:identifier>
                                <prism:require>/content/figures/1477-5751-11-7-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2012-01-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/11/1/6">
        <title>Influences of the G2350A Polymorphism in the ACE Gene on Cardiac Structure and Function of Ball Game Players</title>
        <description>Background:
Except for the I/D polymorphism in the angiotensin I-converting enzyme (ACE) gene, there were few reports about the relationship between other genetic polymorphisms in this gene and the changes in cardiac structure and function of athletes. Thus, we investigated whether the G2350A polymorphism in the ACE gene is associated with the changes in cardiac structure and function of ball game players. Total 85 healthy ball game players were recruited in this study, and they were composed of 35 controls and 50 ball game players, respectively. Cardiac structure and function were measured by 2-D echocardiography, and the G2350A polymorphism in the ACE gene analyzed by the SNaPshot method.
Results:
There were significant differences in left ventricular mass index (LVmassI) value among each sporting discipline studied. Especially in the athletes of basketball disciplines, indicated the highest LVmassI value than those of other sporting disciplines studied (p&lt;0.05). However, there were no significant association between any echocardiographic data and the G2350A polymorphism in the ACE gene in the both controls and ball game players.
Conclusions:
Our data suggests that the G2350A polymorphism in the ACE gene may not significantly contribute to the changes in cardiac structure and function of ball game players, although sporting disciplines of ball game players may influence the changes in LVmassI value of these athletes. Further studies using a larger sample size and other genetic markers in the ACE gene will be needed.</description>
        <link>http://www.jnrbm.com/content/11/1/6</link>
                <dc:creator>Yongwoo Jang</dc:creator>
                <dc:creator>Sung Min Kim</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2012, null:6</dc:source>
        <dc:date>2012-01-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-11-6</dc:identifier>
                                <prism:require>/content/figures/1477-5751-11-6-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2012-01-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/11/1/5">
        <title>Genetic Polymorphisms of Nerve Growth Factor Receptor (NGFR) and the Risk of Alzheimer&apos;s Disease</title>
        <description>Background:
Loss of basal forebrain cholinergic neurons is attributable to the proapoptotic signaling induced by nerve growth factor receptor (NGFR) and may link to Alzheimer&apos;s disease (AD) risk. Only one study has investigated the association between NGFR polymorphisms and the risk of AD in an Italian population. Type 2 diabetes mellitus (DM) may modify this association based on previous animal and epidemiologic studies.
Methods:
This was a case-control study in a Chinese population. A total of 264 AD patients were recruited from three teaching hospitals between 2007 to 2010; 389 controls were recruited from elderly health checkup and volunteers of the hospital during the same period of time. Five common (frequency&gt;=5%) haplotype-tagging single nucleotide polymorphisms (htSNPs) were selected from NGFR to test the association between NGFR htSNPs and the risk of AD.
Results:
Variant NGFR rs734194 was significantly associated with a decreased risk of AD [GG vs. TT copies: adjusted odds ratio (OR)=0.43, 95% confidence interval (CI)=0.20-0.95]. Seven common haplotypes were identified. Minor haplotype GCGCG was significantly associated with a decreased risk of AD (2 vs. 0 copies: adjusted OR=0.39, 95% CI=0.17-0.91). Type 2 DM significantly modified the association between rs2072446, rs741072, and haplotype GCTTG and GTTCG on the risk of AD among ApoE 4 non-carriers (Pinteraction&lt;0.05).
Conclusion:
Inherited polymorphisms of NGFR were associated with the risk of AD; results were not significant after correction for multiple tests. This association was further modified by the status of type 2 DM.</description>
        <link>http://www.jnrbm.com/content/11/1/5</link>
                <dc:creator>Hui-Chi Cheng</dc:creator>
                <dc:creator>Yu Sun</dc:creator>
                <dc:creator>Liang-Chuan Lai</dc:creator>
                <dc:creator>Shih-Yuan Chen</dc:creator>
                <dc:creator>Wen-Chung Lee</dc:creator>
                <dc:creator>Jen-Hau Chen</dc:creator>
                <dc:creator>Ta-Fu Chen</dc:creator>
                <dc:creator>Hua-Hsiang Chen</dc:creator>
                <dc:creator>Li-Li Wen</dc:creator>
                <dc:creator>Ping-Keung Yip</dc:creator>
                <dc:creator>Yi-Min Chu</dc:creator>
                <dc:creator>Wei J. Chen</dc:creator>
                <dc:creator>Yen-Ching Chen</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2012, null:5</dc:source>
        <dc:date>2012-01-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-11-5</dc:identifier>
                                <prism:require>/content/figures/1477-5751-11-5-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2012-01-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/11/1/4">
        <title>A negative screen for mutations in calstabin 1 and 2 genes in patients with dilated cardiomyopathy.</title>
        <description>Background:
Calstabins 1 and 2 bind to Ryanodine receptors regulating muscle excitation-contraction coupling. Mutations in Ryanodine receptors affecting their interaction with calstabins lead to different cardiac pathologies. Animal studies suggest the involvement of calstabins with dilated cardiomyopathy.
Results:
We tested the hypothesis that calstabins mutations may cause dilated cardiomyopathy in humans screening 186 patients with idiopathic dilated cardiomyopathy for genetic alterations in calstabins 1 and 2 genes (FKBP12 and FKBP12.6). No missense variant was found. Five no-coding variations were found but not related to the disease.
Conclusions:
These data corroborate other studies suggesting that mutations in FKBP12 and FKBP12.6 genes are not commonly related to cardiac diseases.</description>
        <link>http://www.jnrbm.com/content/11/1/4</link>
                <dc:creator>Diogo Biagi</dc:creator>
                <dc:creator>Jose Mill</dc:creator>
                <dc:creator>Alfredo Mansur</dc:creator>
                <dc:creator>Jose Krieger</dc:creator>
                <dc:creator>Alexandre Pereira</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2012, null:4</dc:source>
        <dc:date>2012-01-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-11-4</dc:identifier>
                                <prism:require>/content/figures/1477-5751-11-4-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2012-01-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/11/1/3">
        <title>5-Azacytidine Is Insufficient For Cardiogenesis In Human Adipose-Derived Stem Cells </title>
        <description>Background:
Adipose tissue is a source of multipotent adult stem cells and it has the ability to differentiate into several types of cell lineages such as neuron cells, osteogenic cells and adipogenic cells. Several reports have shown adipose-derived stem cells (ASCs) have the ability to undergo cardiomyogenesis. Studies have shown 5-azacytidine can successfully drive stem cells such as bone marrow derived stem cells to differentiate into cardiomyogenic cells. Therefore, in this study, we investigated the effect 5-azacytidine on the cardiogenic ability of ASCs.
Methods:
The cardiogenic potential of ASCs was analysed by studying the morphological changes after induction, the changes in the cardiogenic genes expression i.e. GATA4, MLC-2v, MLC-2a, NKX2.5, beta-MHC, alpha-MHC, Atrial natriuretic peptide (ANP), Connexin 43, Cardiac Troponin C, Cardiac Troponin I and myocyte enhancer factor (MEF2C) and the changes of embryonic stem cells genes expression at P5 and P10 using quantitative PCR.
Results:
Our results showed that the induced ASCs did not show significant morphological difference compared to the non-induced ASCs. While quantitative PCR data indicated that most cardiogenic genes and stemness genes expression level decreased after induction at P5 and P10.
Conclusion:
5-azacytidine is insufficient for the cardiogenic induction of the ASCs.</description>
        <link>http://www.jnrbm.com/content/11/1/3</link>
                <dc:creator>Wan Kamarul Zaman Wan Safwani</dc:creator>
                <dc:creator>Suzana Makpol</dc:creator>
                <dc:creator>Somasundaram Sathapan</dc:creator>
                <dc:creator>Kien Hui Chua</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2012, null:3</dc:source>
        <dc:date>2012-01-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-11-3</dc:identifier>
                                <prism:require>/content/figures/1477-5751-11-3-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2012-01-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/11/1/2">
        <title>Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naive prostate cancer</title>
        <description>Background:
Loss of normal cell cycle control is an early event in the evolution of cancer. The expression of cyclin-dependent kinase (CDK) inhibitors p16 and p27 has been previously associated with progression of prostate cancer (PC). 70 patients diagnosed with early stage PCwere treated with radical prostatectomy (RP) at our institution and their tumor specimens were immunohistochemically evaluated for expression of p16 and p27. Available clinical data of time to PSA recurrence were correlated with the examined parameters and combined with pre-operative PSA level, Gleason score and pathological TNM (pT) stage assessment.
Results:
Nuclear overexpression of p16 was not associated with time to biochemical failure (BF) (p = 0.572). Same was the case for nuclear p27 overexpression (p = 1.000). Also, no significant correlations were found between either p16 or p27, and pre-operative PSA level, pT stage and Gleason grade. pT stage emerged as the only independent prognostic factor for biochemical recurrence (p = 0.01).
Conclusions:
These data question previously reported data supporting the prognostic relevance of both p16 and p27 proteins in early PC.</description>
        <link>http://www.jnrbm.com/content/11/1/2</link>
                <dc:creator>Panagiotis Vlachostergios</dc:creator>
                <dc:creator>Foteini Karasavvidou</dc:creator>
                <dc:creator>Grigorios Kakkas</dc:creator>
                <dc:creator>Kassiani Kapatou</dc:creator>
                <dc:creator>Ioannis Gioulbasanis</dc:creator>
                <dc:creator>Danai Daliani</dc:creator>
                <dc:creator>George Moutzouris</dc:creator>
                <dc:creator>Christos Papandreou</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2012, null:2</dc:source>
        <dc:date>2012-01-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-11-2</dc:identifier>
                                <prism:require>/content/figures/1477-5751-11-2-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2012-01-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/11/1/1">
        <title>The female menstrual cycle does not influence testosterone concentrations in male partners</title>
        <description>Background:
The time of ovulation has since long been believed to be concealed to male heterosexual partners. Recent studies have, however, called for revision of this notion. For example, male testosterone concentrations have been shown to increase in response to olfactory ovulation cues, which could be biologically relevant by increasing sexual drive and aggressiveness. However, this phenomenon has not previously been investigated in real-life human settings. We therefore thought it of interest to test the hypothesis that males&apos; salivary testosterone concentrations are influenced by phases of their female partners&apos; menstrual cycle; expecting a testosterone peak at ovulation.
Methods:
Thirty young, healthy, heterosexual couples were recruited. During the course of 30-40 days, the women registered menses and ovulation, while the men registered sexual activity, physical exercise, alcohol intake and illness (confounders), and obtained daily saliva samples for testosterone measurements. All data, including the registered confounders, were subjected to multiple regression analysis.
Results:
In contrast to the hypothesis, the ovulation did not affect the testosterone levels, and the resulting testosterone profile during the menstrual cycle was on the average flat. The specific main hypothesis, that male testosterone levels on the day of ovulation would be higher than day 4 of the cycle, was clearly contradicted by a type II error(&#946;)-analysis (&lt; 14.3% difference in normalized testosterone concentration; &#946; = 0.05).
Conclusions:
Even though an ovulation-related salivary testosterone peak was observed in individual cases, no significant effect was found on a group level.</description>
        <link>http://www.jnrbm.com/content/11/1/1</link>
                <dc:creator>Jakob Strom</dc:creator>
                <dc:creator>Edvin Ingberg</dc:creator>
                <dc:creator>Emma Druvefors</dc:creator>
                <dc:creator>Annette Theodorsson</dc:creator>
                <dc:creator>Elvar Theodorsson</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2012, null:1</dc:source>
        <dc:date>2012-01-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-11-1</dc:identifier>
                            <dc:title>Menstrual cyle does not affect male testosterone levels</dc:title>
                            <dc:description>The hypothesis that male testosterone concentrations increase with female olfactory ovulation cues is contradicted in a study which monitored thirty couples and established no significant effect, also suggesting no relevance of ovulation to male sexual drive and aggressiveness.</dc:description>
                <prism:require>/content/figures/1477-5751-11-1-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2012-01-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/10/1/16">
        <title>Diagnosis of Tuberculosis : the experience at a specialized diagnostic laboratory  </title>
        <description>This work describes the experience at a tuberculosis clinical laboratory where relatively new TB diagnosis technologies; nucleic acid detection of two target strands, IS6110 and devR, by PCR and microscopic observation drug susceptibility (MODS) were used. The LJ culture was the gold standard. This evaluation was done from August 2007 to July 2009 on 463 sputum samples of tuberculosis suspects at a specialized tuberculosis clinic in Delhi, India.None of the tests we evaluated can accurately detect the presence or absence of Mycobacterium tuberculosis in all the samples and smear microscopy was found to be the most reliable assay in this study.The PCR assay could detect down to 2 pg of H37Rv DNA. Sensitivity, specificity was 0.40, 0.60 and 0.19, 0.81 for smear positive (n = 228) and negative samples (n = 235) respectively. In the MODS assay, sensitivity, specificity of 0.48, 0.52 and 0.38, 0.76 was observed for smear positive and negative samples. Sputum smear microscopy had sensitivity of 0.77 and specificity of 0.70.</description>
        <link>http://www.jnrbm.com/content/10/1/16</link>
                <dc:creator>Anita Mashta</dc:creator>
                <dc:creator>Pooja Mishra</dc:creator>
                <dc:creator>Sonia Philipose</dc:creator>
                <dc:creator>S Tamilzhalagan</dc:creator>
                <dc:creator>Hanif Mahmud</dc:creator>
                <dc:creator>Sangeeta Bhaskar</dc:creator>
                <dc:creator>Pramod Upadhyay</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2011, null:16</dc:source>
        <dc:date>2011-11-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-10-16</dc:identifier>
                                <prism:require>/content/figures/1477-5751-10-16-toc.gif</prism:require>
                <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2011-11-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

